SS
shashank singh
Indian Institute of Integrative Medicine, Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine CSIR, Birla Institute of Technology and Science
0000-0001-8532-7421
Employment
-
Indian Institute of Integrative Medicine Chief Scientist2020 - Present
-
Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine CSIR Scientist2003 - Present
Education
-
Birla Institute of Technology and Science M.Pharm1999 - 2001
Projects & Funding
Projects & funding information is unavailable.
Publications (131)
- Exploring Bioactive Metabolites from Endophytic Fungi of Albizia lebbeck (L.) Benth Save
- (CR)4-Targeted Liposomal Doxorubicin as Promising Therapeutic Approach for Breast Cancer Therapy Save
- Mechanistic Approach into 1,2,3-triazoles-based IIIM(S)-RS98 Mediated Apoptosis in Lung Cancer Cells Save
- Mechanistic Evaluation of Thymoquinone Derivative-Induced Apoptosis in Human Glioblastoma Cells Save
- Metabolite profiling and bioactivity of fungal endofauna from Xiphinema nuragicum in the rhizosphere of Withania somnifera Save
- Novel pyrazole derivatives as inhibitors of Leishmania donovani: an integrated approach combining in vitro analysis and mechanistic insights Save
- Synthesis of benzenesulfonamide tethered pyrazolyl stilbene derivatives: Their anti-proliferative and carbonic anhydrase inhibitory potentials Save
- Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells Save
- 1,2,3-Triazole Tethered Hybrid Capsaicinoids as Antiproliferative Agents Active against Lung Cancer Cells (A549) (vol 7, pg 32078, 2022) Save
- In Vitro and In Silico Anticancer Evaluation of Secondary Metabolites from an Endophytic Fungus Aspergillus Fumigatus Isolated from Monarda Citriodora Save